Arcadia Biosciences, Inc. (RKDA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.1M | 901K | 1.3M | 1.46M | 1.2M | 1.22M | 1.54M | 1.31M | 987K | 1.17M | 1.3M | 1.3M |
| Revenue Growth % | -8.33% | -25.9% | -15.29% | 11.41% | 21.58% | 3.93% | 18.41% | 0.69% | -19.89% | 17% | -17.32% | -66.38% |
| Cost of Goods Sold | 700K | 709K | 884K | 824K | 682K | 827K | 1.03M | 633K | 471K | 670K | 818K | 650K |
| COGS % of Revenue | 63.64% | 78.69% | 67.9% | 56.63% | 56.83% | 68.01% | 67.14% | 48.47% | 47.72% | 57.27% | 63.02% | 50.12% |
| Gross Profit | 400K | 192K | 418K | 631K | 518K | 389K | 505K | 673K | 516K | 500K | 480K | 647K |
| Gross Margin % | 36.36% | 21.31% | 32.1% | 43.37% | 43.17% | 31.99% | 32.86% | 51.53% | 52.28% | 42.73% | 36.98% | 49.88% |
| Gross Profit Growth % | -22.78% | -50.64% | -17.23% | -6.24% | 0.39% | -22.2% | 5.21% | 4.02% | -5.15% | 190.58% | 8.6% | 57.42% |
| Operating Expenses | 1.18M | 1.57M | 1.83M | 6.62M | 1.74M | 2.67M | 2.27M | -1.31M | 2.1M | 3.86M | 1.88M | 2.1M |
| OpEx % of Revenue | 107.18% | 173.92% | 140.32% | 455.05% | 144.83% | 219.41% | 147.36% | -100.08% | 213.17% | 330.26% | 144.61% | 161.99% |
| Selling, General & Admin | 1.18M | 1.57M | 1.57M | 2.12M | 1.74M | 2.65M | 2.24M | 2.68M | 2.06M | 3.42M | 1.86M | 2.07M |
| SG&A % of Revenue | 107.18% | 173.92% | 120.58% | 145.91% | 144.83% | 218.34% | 145.8% | 205.44% | 208.92% | 292.56% | 143.45% | 159.91% |
| Research & Development | 0 | 0 | 0 | 9K | 0 | 13K | 24K | 10K | 6K | 332K | 15K | 27K |
| R&D % of Revenue | - | - | - | 0.62% | - | 1.07% | 1.56% | 0.77% | 0.61% | 28.38% | 1.16% | 2.08% |
| Other Operating Expenses | 0 | 0 | 257K | 1000K | 0 | 0 | 0 | -1000K | 36K | 109K | 0 | 0 |
| Operating Income | -779K | -1.38M | -1.41M | -5.99M | -1.22M | -2.28M | -1.76M | 1.98M | -1.59M | -3.36M | -1.4M | -1.45M |
| Operating Margin % | -70.82% | -152.61% | -108.22% | -411.68% | -101.67% | -187.42% | -114.51% | 151.61% | -160.89% | -287.52% | -107.63% | -112.1% |
| Operating Income Growth % | 36.15% | 39.67% | 19.94% | -402.53% | 23.17% | 32.25% | -25.98% | 236.18% | 58.93% | 42.3% | 65% | 61.56% |
| EBITDA | -771K | -1.37M | -1.41M | -5.97M | -1.21M | -2.26M | -1.75M | 2.01M | -1.54M | -3.3M | -1.31M | -1.39M |
| EBITDA Margin % | -70.09% | -152.39% | -108.06% | -410.65% | -100.58% | -185.69% | -114.05% | 154.21% | -155.72% | -282.39% | -100.77% | -106.94% |
| EBITDA Growth % | 36.12% | 39.19% | 19.74% | -396.67% | 21.47% | 31.66% | -34.02% | 245.21% | 59.51% | 42.48% | 66.47% | 61.92% |
| D&A (Non-Cash Add-back) | 8K | 2K | 2K | 15K | 13K | 21K | 7K | 34K | 51K | 60K | 89K | 67K |
| EBIT | -779K | -1.38M | -1.41M | -5.99M | -1.22M | -2.28M | -1.76M | -2.02M | -1.55M | -3.25M | -1.4M | -1.45M |
| Net Interest Income | 5K | 0 | 7K | 9K | 207K | 354K | 233K | 150K | 45K | 157K | 133K | 207K |
| Interest Income | 5K | 0 | 7K | 9K | 207K | 354K | 233K | 150K | 45K | 157K | 133K | 207K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -3.61M | 47K | 2.27M | 1.53M | 3.82M | -1.75M | 578K | -130K | 641K | 748K | 758K | 4.61M |
| Pretax Income | -4.38M | -1.33M | 856K | -4.46M | 2.6M | -4.03M | -1.18M | 1.85M | -947K | -2.62M | -639K | 3.16M |
| Pretax Margin % | -398.64% | -147.39% | 65.75% | -306.39% | 216.58% | -331.33% | -76.9% | 141.65% | -95.95% | -223.59% | -49.23% | 243.33% |
| Income Tax | 0 | 8K | 0 | 0 | 0 | 8K | 0 | 0 | 0 | 7K | 0 | 1K |
| Effective Tax Rate % | 0% | -0.6% | 0% | 0% | 0% | -0.2% | 0% | 0% | 0% | -0.27% | 0% | 0.03% |
| Net Income | -4.38M | -1.34M | 856K | -4.46M | 2.6M | -4.06M | -1.61M | 1.06M | -2.42M | -2.85M | -2.57M | 823K |
| Net Margin % | -398.64% | -148.28% | 65.75% | -306.39% | 216.58% | -334.21% | -104.88% | 81.24% | -245.49% | -243.85% | -197.77% | 63.45% |
| Net Income Growth % | -268.72% | 67.13% | 153.1% | -520.17% | 207.26% | -42.45% | 37.2% | 28.92% | 74.18% | 32.78% | 10.46% | 121.79% |
| Net Income (Continuing) | -4.38M | -1.34M | 856K | -4.46M | 2.6M | -4.04M | -1.18M | 1.85M | -947K | -2.62M | -639K | 3.15M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | -27K | -430K | -789K | -1000K | -230K | -1000K | -1000K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -138K | -138K | -138K | -138K | -138K | -138K |
| EPS (Diluted) | -3.21 | -0.98 | 0.62 | -3.26 | 1.90 | -2.98 | -1.18 | 0.78 | -1.78 | -2.22 | -1.89 | 0.60 |
| EPS Growth % | -268.95% | 67.11% | 152.54% | -517.95% | 206.74% | -34.23% | 37.57% | 30% | 83.61% | 68.42% | 59.7% | 108.81% |
| EPS (Basic) | -3.21 | -0.98 | 0.63 | -3.26 | 1.90 | -2.98 | -1.18 | 0.78 | -1.78 | -2.22 | -1.89 | 0.60 |
| Diluted Shares Outstanding | 1.37M | 1.37M | 1.37M | 1.37M | 1.37M | 1.36M | 1.36M | 1.36M | 1.36M | 1.29M | 1.36M | 1.36M |
| Basic Shares Outstanding | 1.37M | 1.37M | 1.37M | 1.37M | 1.37M | 1.36M | 1.36M | 1.36M | 1.36M | 1.29M | 1.36M | 1.36M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |